Topics

Navigating the Rare Disease Space: Insights from a Danish CEO

03:00 EST 28 Nov 2018 | Labiotech.eu

Developing drugs for rare diseases is a tough nut for biotech companies to crack. Labiotech’s Helen Albert interviewed the CEO of the Danish company Orphazyme, Anders Hinsby, at the recent BIO-Europe conference in Copenhagen, who told her about the appeals ...

The post Navigating the Rare Disease Space: Insights from a Danish CEO appeared first on Labiotech.eu.

Original Article: Navigating the Rare Disease Space: Insights from a Danish CEO

NEXT ARTICLE

More From BioPortfolio on "Navigating the Rare Disease Space: Insights from a Danish CEO"

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...